1. García Rafanell J., Morell J. (1977): L’effect inhibiteur de l’acide 2-acetoxy-4-trifluoromethyl benzoique (triflusal) et de l’aspirine sur l’aggregation des plaquettes chez l’home et le rat Etude “in vivo”. Therapie, 32, 337–344.
2. García Rafanell J., Planas J.M., Puig Parellada P. (1979): Biochemical profile of a new antithrombotic agent: triflusal (UR-1501). Arch. Int. Pharmacodyn. Ther., 237, 343–350.
3. Sancho MJ., Castellamau C., Villa L., et al. (1985): Effects of salicylate derivatives on cyclooxygenase interaction studies. Biol. din. Hematol., 7, 135–143.
4. Garcia Rafanell J., Forn J. (1982): Intravenous arachidonate-induced respiratory distress: comparative study of three in vivo models for the measurement of antithrombotic activity. J. Pharmacol. Meth., 7, 231–238.
5. Gómez L., Garcia Rafanell J., Forn J. (1987): Protective effect of triflusal and acetylsalicylic acid against arachidonic acid induced cerebrovascular occlusion in anaesthetized rats. Meth. Fin. Exp. Clin. Pharmacol., 9, 13–17.